Voluntary Male Circumcision as part of the national Program and the Combination Prevention project in Botswana under the President’s Emergency Plan for AIDs Relief | CDC RFA GH15 150602CONT17

Opportunity Information: Apply for CDC RFA GH15 150602CONT17

This funding opportunity is a continuation cooperative agreement from the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (CDC), Center for Global Health, focused on supporting voluntary medical male circumcision (VMMC) in Botswana as part of the country’s national HIV prevention programming and broader combination prevention efforts under the President's Emergency Plan for AIDS Relief (PEPFAR). The opportunity is identified as CDC RFA GH15-150602CONT17 and is cataloged under CFDA 93.067, which aligns with international HIV/AIDS prevention and related public health activities. As a continuation action, it is structured to sustain or build upon existing work rather than start a brand-new competitive program from scratch, and it anticipates a single award.

Programmatically, the grant centers on VMMC as a proven biomedical HIV prevention intervention, implemented within the national program framework in Botswana and positioned as one component of combination prevention. Combination prevention typically means coordinating multiple strategies at once such as HIV testing and counseling, linkage to and retention in treatment, condom promotion, risk-reduction counseling, prevention of mother-to-child transmission support, sexually transmitted infection services, and other targeted interventions for populations at higher risk. In this context, VMMC is treated as a key service that can reduce the risk of heterosexual HIV acquisition in males and, when delivered at sufficient scale and quality, contributes to population-level reductions in new infections. The opportunity description indicates the work is intended to align with national priorities and implementation structures in Botswana while also meeting PEPFAR goals and CDC technical standards.

As a cooperative agreement rather than a standard grant, the award mechanism signals substantial programmatic involvement by the CDC. In practical terms, that typically includes close collaboration on planning, implementation approaches, quality assurance, monitoring and evaluation, and alignment with PEPFAR reporting requirements and national ministry policies. Cooperative agreements often emphasize joint problem-solving, adherence to clinical and program guidelines, data-driven performance management, and continuous improvement in service delivery. For a VMMC-focused program, that usually translates into attention to clinical safety and infection prevention, provider training and certification, demand creation and community engagement that maintains voluntariness, ethical informed consent practices, referral pathways for HIV testing and treatment services, post-procedure follow-up, and adverse event monitoring and reporting.

The listing specifies an award ceiling of 0, which generally indicates the ceiling was not stated in the synopsis or was to be determined through internal continuation budgeting rather than published as a set maximum. The expected number of awards is 1, consistent with a continuation action that supports an incumbent or an existing implementing partner arrangement. The eligibility field notes "Others (see text field entitled Additional Information on Eligibility for clarification)," which usually means the announcement contains additional detail on which organizations may apply, often tied to continuation status, existing cooperative agreement holders, or specific types of entities that meet program requirements.

Administratively, the opportunity was created on October 5, 2016, with an original closing date of December 8, 2016, situating it within the funding cycle where the CDC and PEPFAR were continuing country-level prevention investments. The activity category is Health, reinforcing that the program is meant to deliver and strengthen public health services, systems, and outcomes rather than conduct basic research.

Overall, the opportunity is best understood as CDC support for sustaining and strengthening Botswana’s VMMC service delivery as a core HIV prevention intervention under PEPFAR, integrated into a broader combination prevention package. The focus is on maintaining a coordinated, high-quality, and data-accountable program that fits Botswana’s national HIV strategy while meeting U.S. government global health objectives and CDC program standards.

• The Department of Health and Human Services, Centers for Disease Control - CGH in the health sector is offering a public funding opportunity titled "Voluntary Male Circumcision as part of the national Program and the Combination Prevention project in Botswana under the President’s Emergency Plan for AIDs Relief" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
• This funding opportunity was created on Oct 05, 2016.
• Applicants must submit their applications by Dec 08, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 1 candidate(s).
• Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).

Apply for CDC RFA GH15 150602CONT17

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: